“Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction ” (2014) Journal of Pharmacy and Nutrition Sciences, 4(3), pp. 170–176. doi:10.6000/1927-5951.2014.04.03.1.